Article
Adipose-derived Mesenchymal Stem Cell Therapy for Reverse Bleomycin-induced Experimental Pulmonary Fibrosis
2021-10-21
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Idiopathic pulmonary fibrosis (IPF) is a chronic progressive respiratory disease. Arguably, the complex interplay between immune cell subsets, coupled with an incomplete understanding in disease pathophysiology, have contributed to the paucity of successful therapies. In turn, IPF remains a fatal disease at present. Thus, with no effective therapy for either the...
Topics
Open a Topic to create a Post that cites this publication.
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Mesenchymal stem cell research
- Neonatal Respiratory Health Research
- Occupational exposure and asthma
- Pleural and Pulmonary Diseases
- Pulmonary Hypertension Research and Treatments
- Tissue Engineering and Regenerative Medicine
Identifiers and source
- Literature Corpus work
- cbf36f4a-9b27-534c-bb6a-6eef9ebdd097
- DOI
- 10.21203/rs.3.rs-977764/v1
